Editor’s Note:
While this article references enforcement activity and regulatory updates initially highlighted in 2023, hospice medical director compensation remains an area of heightened scrutiny. Regulators continue to focus on physician relationships, certification practices, and payment arrangements, making defensible fair market value (FMV) analysis and documentation critical.
Heightened Oversight of Hospice Arrangements
In 2023, CMS made several hospice-focused announcements signaling increased oversight related to hospice ownership, physician enrollment, and medical director arrangements. That scrutiny has continued, as regulators and law enforcement prioritize fraud prevention in hospice care.
Hospice patients represent a vulnerable population, and both CMS and the Department of Justice (DOJ) continue to emphasize enforcement in this area. Hospice-related investigations frequently focus on physician relationships, certification practices, and compensation structures—particularly where payments may be viewed as influencing referrals or admissions.
Representative Enforcement Actions
While some of the most prominent hospice enforcement actions occurred several years ago, these cases continue to shape how CMS, the DOJ, and the Office of Inspector General (OIG) evaluate hospice medical director compensation arrangements today.
Recent enforcement trends continue to highlight:
- Payments to physicians that exceed fair market value
- Compensation not supported by actual services performed
- Arrangements that appear tied to patient admissions or census
- Lack of documentation supporting duties, time, and need
These themes remain central to current enforcement activity and underscore the importance of properly structured and supported compensation arrangements.
Medicare Hospice Physician Enrollment Requirements
CMS has strengthened program integrity requirements by requiring physicians who order or certify hospice services to be enrolled in Medicare or validly opted out.
These requirements improve CMS’s ability to:
- Verify physician qualifications
- Monitor certification activity
- Identify potential fraud and abuse risks
As a result, physician relationships—including medical director roles—are subject to increased scrutiny, particularly where certification authority intersects with financial arrangements.
Fair Market Value of Hospice Medical Director Compensation
Hospice medical directors serve a critical role in certifying eligibility and overseeing patient care, making their compensation arrangements a key focus area for regulators.
A well-supported, third-party fair market value and commercial reasonableness opinion can be a critical risk-mitigation tool when responding to fraud and abuse allegations or government inquiries.
Unlike home health agencies, hospices are required to have a medical director under Medicare’s Conditions of Participation. Medical directors are directly involved in certifying that patients meet eligibility requirements for hospice care, reinforcing the need for compensation arrangements that are both defensible and aligned with actual services performed.
Medicare hospice payment rates are intended to cover physicians’ administrative and general supervisory activities. As a result, any separate medical director compensation must reflect:
- Clearly defined duties
- Actual services performed
- Reasonable time commitments
- Market-based compensation levels
Supporting Fair Market Value and Commercial Reasonableness
Market data on hospice medical director compensation demonstrates a relationship between physician pay and hospice size, typically measured by operating expenses, census, or revenue. Fair market value analysis generally considers:
- Hourly compensation benchmarks for hospice and palliative care physicians
- Agency size and operational complexity
- Scope of duties and responsibilities
- Physician specialty, training, and experience
- Time requirements and administrative burden
Equally important is commercial reasonableness, which evaluates whether the arrangement makes sense operationally—not just financially.
Documentation is critical. Hospice agencies should maintain clear records of:
- Duties performed
- Time spent
- Alignment with contracted responsibilities
- Ongoing need for the role
This documentation helps support both FMV and commercial reasonableness in the event of regulatory review.
Hospice agencies should also consult legal counsel to ensure arrangements meet applicable Stark Law exceptions and Anti-Kickback Statute safe harbors.
Why This Matters in Today’s Environment
Hospice remains an area of heightened regulatory focus due to:
- Vulnerable patient populations
- Physician certification requirements
- Direct financial relationships with providers
Common risk areas in medical director arrangements include:
- Compensation disconnected from actual services
- Agreements that are outdated or not followed in practice
- Payments for minimal or undefined duties
- Compensation structures that could be perceived as tied to referrals
As enforcement activity continues, organizations are increasingly expected to demonstrate that compensation arrangements are both defensible and well-documented.
How LBMC Can Help
LBMC has helped hospice agencies develop compliant medical director compensation models supported by fair market value and commercial reasonableness analysis.
Our team evaluates:
- Agency size and structure
- Scope of services and time requirements
- Market compensation benchmarks
- Documentation and defensibility of arrangements
We work with hospice organizations to support compensation strategies that align with regulatory expectations and reduce exposure to enforcement risk.
Content provided by the LBMC Healthcare Compensation Valuation team.
Hospice Medical Director Compensation FAQs: FMV and Compliance
What is hospice medical director compensation?
Hospice medical director compensation refers to payments made to physicians for administrative, supervisory, and certification responsibilities within a hospice organization.
Why is hospice medical director compensation a compliance focus?
Because medical directors play a central role in certifying patient eligibility, compensation arrangements may be scrutinized if they appear to influence referrals or admissions.
What makes hospice medical director compensation fair market value?
Fair market value means the compensation is consistent with what an unrelated party would pay for similar services, considering duties, time commitment, specialty, and hospice size.
What should be included in a medical director agreement?
Agreements should clearly define duties, expected time, compensation methodology, term, and documentation requirements for services performed.
Why is commercial reasonableness important in addition to FMV?
An arrangement can be at market rates but still noncompliant if the services are not necessary, are duplicative, or lack operational justification.
What are common red flags in hospice medical director arrangements?
Red flags include:
- Payments not tied to actual services
- Excessive compensation relative to duties
- Lack of documentation
- Compensation influenced by referrals or census
How can hospice providers reduce compliance risk?
Providers should:
- Document duties and time spent
- Use market data to support compensation
- Obtain independent FMV opinions
- Periodically review and update agreements
How often should hospice compensation arrangements be reviewed?
Compensation arrangements should be reviewed regularly—especially when hospice size, census, regulatory requirements, or market benchmarks change.
